Effects of Quercetin on Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis
Dachuan Jin, Shunqin Jin, Tao Zhou, Guoping Sheng, Peng Gao, Guangming Li · 2025
Read Effects of Quercetin on Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis by Dachuan Jin, Shunqin Jin, Tao Zhou, Guoping Sheng, Peng Gao, Guangming Li (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12703814.txt.
Description
Jin and five co-authors meta-analyze quercetin for fatty liver disease tied to metabolic dysfunction, in a review from twenty twenty-five. The plant compound is proposed to help liver and lipid health. Seven randomized trials with five hundred forty patients are pooled. Liver enzymes, lipids, inflammation, and body measures are tracked.
Quercetin lowers liver enzymes and an inflammation marker significantly. Total cholesterol, LDL, and triglycerides fall while HDL rises. Kidney function, weight, and body fat show no significant change. Certainty of evidence ranges from very low to moderate. Larger, better trials must confirm any therapeutic role.
Catalog record
| CREATOR | Dachuan Jin, Shunqin Jin, Tao Zhou, Guoping Sheng, Peng Gao, Guangming Li |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |